Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Chelsea Therapeutics
International, Ltd. (“Chelsea” or the “Company”) (Nasdaq: CHTP) relating
to the proposed acquisition by H. Lundbeck A/S (“Lundbeck”).
Click here to learn more about the investigation http://brodsky-smith.com/756-chtp-chelsea-therapeutics-international-ltd.html,
or call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Chelsea shareholders will receive
only $6.44 in cash and up to an additional $1.50 in a Contingent Value
Right for each share of Chelsea stock they own. The investigation
concerns possible breaches of fiduciary duty and other violations of
state law by the Board of Directors of Chelsea for not acting in the
Company’s shareholders' best interests in connection with the sale
process. The transaction may undervalue the Company given the strong
demand for Chelsea’s recently FDA-approved Parkinson’s disease treatment
Northera, which treats low blood pressure. In addition, an analyst has
set a $12.00 per share price target on Chelsea stock.
If you own shares of Chelsea common stock and wish to discuss the legal
ramifications of the proposed transaction, or have any questions, you
may e-mail or call the law office of Brodsky & Smith, LLC who will,
without obligation or cost to you, attempt to answer your questions. You
may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at
Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004,
by e-mail at investorrelations@brodsky-smith.com,
by visiting http://brodsky-smith.com/756-chtp-chelsea-therapeutics-international-ltd.html,
or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise
representing shareholders throughout the nation in securities and case
action lawsuits. The attorneys at Brodsky & Smith have been appointed by
numerous courts throughout the country to serve as lead counsel in class
actions and successfully recovered millions of dollars for our clients
and shareholders. Attorney advertising. Prior results do not guarantee a
similar outcome.
Copyright Business Wire 2014